Global Medical Oxygen Concentrators Market by Application, Types, End-User, Regional Analysis and Forecast to 2016 - 2024 Date: 03-07-2017 07:39 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Medical Devices
Inogen, Inc., Koninklijke Philips N.V., Chart Industries, Inc., and Invacare Corporation had collectively taken up 65.5% of the global medical oxygen concentrators market in 2015, pointing towards a highly consolidated market. Each of the above key players hold a considerable hold over the global medical oxygen concentrators market through a consistent rate of introduction of newer technologies. Transparency Market Research states in a research report that the leaders in the global medical oxygen concentrators market take a sizeable portion of the market in terms of value. Their strongly established brand image helps keep their client pool intact and allows them to progress much faster in terms of research and development. Leaders in the global medical oxygen concentrators market also hold solid distribution networks within their core areas, making it even harder for new entrants to generate traction. The global medical oxygen concentrators market does face a moderate level of threat from substitutes such as oxygen therapy devices and liquid and gaseous oxygen cylinders, further creating a measurable barrier for players to climb. The global medical oxygen concentrators market is projected to reach US$2.41 bn by the end of 2024, after expanding at a CAGR of 8.5% within a forecast period from 2016 to 2024. The market was calculated to reach US$1.25 bn by the end of 2016. Download Exclusive Brochure of This Report : www.transparencymarketresearch.com/sample/sample.php?flag... Demand for Medical Oxygen Concentrators Ramped with COPD Patient Numbers on the Rise “Chronic obstructive pulmonary disease, according to the WHO, is currently the fourth-leading cause of death, with close to 2.75 mn patients dying every year. COPD is further estimated to become the third-leading cause of death globally by 2030. The CDC adds that more than 16 mn U.S. citizens are currently living with lung cancer, COPD, smoking-related heart diseases, and other respiratory disorders. These numbers are vital to the global medical oxygen concentrators market, as these patients are the core consumers of concentrated oxygen. Their difficulty in breathing compels them to inhale larger volumes of
Seite 1 / 3